BioSpace News Archive

Intra-Cellular Therapies, Inc., a biopharmaceutical company, announced that it has commenced an underwritten public offering of $350 million of shares of its common stock.

Varian (NYSE: VAR) today announced the German Cancer Research Center (DKFZ) in Heidelberg has ordered Germany’s first Ethos™ therapy, an Adaptive Intelligence™ solution.

Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Michael Clayman, M.D., President and Chief Executive Officer, will participate in an analyst-led fireside chat at the H.C. Wainwright Virtual Healthcare Conference. The virtual fireside chat is scheduled to begin at 10:00 a.m. ET on Tuesday, September 15, 2020. To access the live webcast of the presentation, please visit the Flexion website at http://ir.flexiontherapeutics.c

Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the Company’s management will present an overview and update, as well as host investor meetings, at the Morgan Stanley 18 th Annual Global Healthcare Conference on Wednesday, September 16, 2020, at 2:00 p.m. ET. Investors interested in arr

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which combine real-time Magnetic Resonance Imaging (“MRI”), thermal ultrasound and closed-loop temperature feedback control for the radiation-free ablation of diseased tissue, announced today that management will present an update on the Company’s business at the Cantor Virtual Global Healthcare Conference

The MemorialCare Heart & Vascular Institute at Long Beach Medical Center is expanding its leadership team with accomplished Southern California cardiologist, David Shavelle, M.D., being named medical director of adult cardiology.

- Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide, today announced that company management will participate in a fireside chat at the 2020 Cantor Virtual Global Healthcare Conference on Wednesday, September 16, 2020 at 11:00 a.m. ET. A live webc

Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on developing immune modulators and precision therapies for solid tumor cancers, today announced that Tom Civik, Chief Executive Officer of Five Prime Therapeutics, and Helen Collins, M.D., Executive Vice President and Chief Medical Officer of Five Prime Therapeutics

Baxter International Inc., a leading global medical products company, will host a conference call to discuss its third-quarter 2020 financial results on Thursday, October 29, 2020, at 7:30 a.m. Central Time.

Since 1889, Mentholatum® Cough and Cold products have provided soothing relief for families during cold and flu season with trusted formulas and innovative topical solutions